Price target upside
Rein Therapeutics, Inc. Price Target: +644.4% vs Current Price
RNTX target gap is +644.4% from $0.81 to $6.00. As of 2026-08-15.
Direct answer
Rein Therapeutics, Inc.'s analyst target implies +644.4%.
The average target is $6.00 compared with a recorded current price of $0.81.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 15, 2026.
Get free Rein Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.81
- Average price target
- $6.00
- High price target
- $8.00
- Low price target
- $4.00
- Target upside
- +644.4%
- Consensus rating
- Strong Buy
- Analysts
- 2
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026